Ultrasound-responsive nanoplatforms for cancer immunotherapy: engineering spatiotemporal immune activation in the tumor microenvironment
Immune checkpoint blockade has reshaped cancer therapy, but durable responses remain limited by insufficient antigen release, poor T-cell infiltration, immunosuppressive tumor microenvironments, and systemic immune-related toxicity. Ultrasound-responsive nanoplatforms provide a spatiotemporally controllable strategy to...